http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26149517

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Comparative Study|Journal Article
endingPage 4
issn 1543-0790
issueIdentifier 11
pageRange 852-4
publicationName Clinical advances in hematology & oncology : H&O
startingPage 852
bibliographicCitation S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer. Clin Adv Hematol Oncol. 2005 Nov;3(11):852–4. PMID: 16491627.
date 200511
identifier https://pubmed.ncbi.nlm.nih.gov/16491627
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32465
https://portal.issn.org/resource/ISSN/1543-0790
language English
source https://pubmed.ncbi.nlm.nih.gov/
title S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer
discusses http://id.nlm.nih.gov/mesh/M0006270
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0197524
http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0006519
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D004164Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D007093Q000008
http://id.nlm.nih.gov/mesh/D000077557
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015996
http://id.nlm.nih.gov/mesh/D000077211
http://id.nlm.nih.gov/mesh/D017024
http://id.nlm.nih.gov/mesh/D004002Q000008
http://id.nlm.nih.gov/mesh/D011237

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128627634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 35.